Wilsey Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Wilsey Asset Management's PFE Position: Q2 2026 in Review
Wilsey Asset Management increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $5.3M and bringing the position to 1,390,058 shares worth $33.5M. The position accounts for 4.92% of the portfolio, ranked #13.
Wilsey Asset Management first reported a position in PFE in Q4 2013 and has held it in 17 quarters since. 1,309 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wilsey Asset Management held 1,390,058 shares of Pfizer worth $33.5M as of Q2 2026.
- Wilsey Asset Management bought 202,641 Pfizer shares in Q2 2026, an estimated $5.3M.
- Pfizer made up 4.92% of Wilsey Asset Management's portfolio in Q2 2026, its #13 holding.
- Wilsey Asset Management first reported a position in Pfizer in Q4 2013 and has held it in 17 quarters since.
- 1,309 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wilsey Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.